KRAS and BRAF Mutations, Histopathological Features and Tumor Budding in Bangladeshi Patients with Colorectal Carcinoma
Background: KRAS and BRAF mutations predict resistance to antibodies against the epidermal growth factor receptor (EGFR) in colorectal carcinoma (CRC), but Bangladeshi data are scarce. This study determined KRAS and BRAF mutation frequencies in resected CRC and their associations with clinicopathological features and t...